Earnings Feed
Start Free
Viridian Therapeutics, Inc.\DE·4

Jun 28, 4:05 PM ET

Morris Arlene 4

4 · Viridian Therapeutics, Inc.\DE · Filed Jun 28, 2024

Insider Transaction Report

Form 4
Period: 2024-06-26
Viridian Therapeutics, Inc.\DEVRDN
Morris Arlene
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-26+21,000→ 21,000 total
    Exercise: $12.31Exp: 2034-06-26→ Common Stock (21,000 underlying)
Footnotes (1)
  • [F1]The option vests in full upon the earlier to occur of (i) June 26, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board.

Documents

2 files